Abrdn Life Sciences Investors (HQL) News Today $14.29 +0.08 (+0.56%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Allspring Global Investments Holdings LLC Sells 66,319 Shares of Abrdn Life Sciences Investors (NYSE:HQL)Allspring Global Investments Holdings LLC lowered its position in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 19.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 280,302 shares of the company's stockOctober 29, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Short Interest Down 16.1% in AugustAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) saw a significant decline in short interest during the month of August. As of August 15th, there was short interest totalling 221,500 shares, a decline of 16.1% from the July 31st total of 264,100 shares. Based on an average trading volume of 93,600 shares, the short-interest ratio is currently 2.4 days.September 3, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC decreased its stake in Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 19.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 346,621 shares of the companySeptember 2, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Declares Dividend Increase - $0.49 Per ShareAbrdn Life Sciences Investors (NYSE:HQL) announced a quarterly dividend on Monday, August 12th. Investors of record on Friday, August 23rd will be paid a dividend of 0.49 per share on Monday, September 30th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 12.92%. The ex-dividend date is Friday, August 23rd. This is a boost from Abrdn Life Sciences Investors's previous quarterly dividend of $0.48.August 12, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Short Interest Up 4,978.8% in JulyAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totalling 264,100 shares, an increase of 4,978.8% from the July 15th total of 5,200 shares. Based on an average daily trading volume, of 96,800 shares, the days-to-cover ratio is currently 2.7 days.August 12, 2024 | marketbeat.com16 Big Dividends We’re Avoiding Like Right NowFew people pay much attention to the management team of a closed-end fund (CEF). But it’s becoming a much more critical factor driving CEF upside (andAugust 7, 2024 | marketbeat.comCetera Advisors LLC Makes New Investment in Abrdn Life Sciences Investors (NYSE:HQL)Cetera Advisors LLC purchased a new stake in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 141,526 shares of the company's stock, valued at approximately $1,929,000.August 7, 2024 | marketbeat.comCornerstone Advisors LLC Sells 462,426 Shares of Abrdn Life Sciences Investors (NYSE:HQL)Cornerstone Advisors LLC trimmed its position in Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 93.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,914 shares of the company's stock after selling 462,426 sharesJuly 21, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Director Rose Dimartino Acquires 1,000 SharesJuly 19, 2024 | insidertrades.comRose Dimartino Acquires 1,000 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) Director Rose Dimartino acquired 1,000 shares of Abrdn Life Sciences Investors stock in a transaction dated Tuesday, July 16th. The shares were bought at an average cost of $15.53 per share, with a total value of $15,530.00. Following the completion of the purchase, the director now owns 1,000 shares in the company, valued at $15,530. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.July 18, 2024 | marketbeat.comSaba Capital Management, L.P. Purchases 13,812 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockJune 26, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $33,312.00 in StockJune 15, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Buys $33,312.00 in StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 2,400 shares of the stock in a transaction that occurred on Wednesday, June 12th. The stock was acquired at an average cost of $13.88 per share, with a total value of $33,312.00. Following the completion of the purchase, the insider now owns 3,407,612 shares of the company's stock, valued at $47,297,654.56. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.June 14, 2024 | marketbeat.comSaba Capital Management, L.P. Purchases 9,704 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockJune 12, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $133,041.84 in StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 9,704 shares of Abrdn Life Sciences Investors stock in a transaction that occurred on Monday, June 10th. The stock was bought at an average cost of $13.71 per share, for a total transaction of $133,041.84. Following the purchase, the insider now directly owns 3,403,173 shares in the company, valued at $46,657,501.83. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.June 11, 2024 | marketbeat.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Buys 9,598 Shares of StockJune 11, 2024 | insidertrades.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires 9,598 Shares of StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 9,598 shares of Abrdn Life Sciences Investors stock in a transaction on Thursday, June 6th. The shares were bought at an average price of $13.80 per share, for a total transaction of $132,452.40. Following the purchase, the insider now owns 3,389,706 shares of the company's stock, valued at $46,777,942.80. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.June 10, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 33,357 SharesJune 6, 2024 | insidertrades.comSaba Capital Management, L.P. Buys 33,357 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 33,357 shares of the business's stock in a transaction on Tuesday, June 4th. The shares were bought at an average cost of $13.50 per share, for a total transaction of $450,319.50. Following the completion of the transaction, the insider now directly owns 3,354,025 shares in the company, valued at approximately $45,279,337.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.June 5, 2024 | marketbeat.comShort Interest in Abrdn Life Sciences Investors (NYSE:HQL) Rises By 26.0%Abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 73,600 shares, an increase of 26.0% from the April 30th total of 58,400 shares. Based on an average trading volume of 83,200 shares, the short-interest ratio is currently 0.9 days.June 1, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 8,714 SharesJune 1, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $17,590.50 in StockMay 24, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 1,303 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. bought 1,303 shares of the firm's stock in a transaction that occurred on Thursday, May 23rd. The stock was purchased at an average price of $13.50 per share, with a total value of $17,590.50. Following the completion of the purchase, the insider now owns 3,251,883 shares in the company, valued at $43,900,420.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.May 23, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Raises Dividend to $0.48 Per ShareAbrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Thursday, May 9th. Stockholders of record on Thursday, May 23rd will be paid a dividend of 0.48 per share on Friday, June 28th. This represents a $1.92 annualized dividend and a dividend yield of 13.62%. The ex-dividend date is Wednesday, May 22nd. This is a boost from Abrdn Life Sciences Investors's previous quarterly dividend of $0.39.May 20, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Shares Purchased by Cornerstone Advisors LLCCornerstone Advisors LLC raised its position in Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 73.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 494,340 shares of the company's stock after purchasing an addMay 19, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $493,173.45 in StockMay 18, 2024 | insidertrades.comSaba Capital Management, L.P. Purchases 34,755 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. bought 34,755 shares of the business's stock in a transaction that occurred on Wednesday, May 15th. The shares were bought at an average cost of $14.19 per share, with a total value of $493,173.45. Following the completion of the purchase, the insider now directly owns 3,250,580 shares of the company's stock, valued at approximately $46,125,730.20. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.May 17, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 57,862 SharesMay 15, 2024 | insidertrades.comSaba Capital Management, L.P. Purchases 57,862 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 57,862 shares of the stock in a transaction dated Friday, May 10th. The stock was acquired at an average price of $13.86 per share, for a total transaction of $801,967.32. Following the completion of the transaction, the insider now directly owns 3,215,825 shares of the company's stock, valued at $44,571,334.50. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.May 14, 2024 | marketbeat.comSaba Capital Management buys abrdn Life Sciences shares worth $390kMay 12, 2024 | uk.investing.comSaba Capital Management, L.P. Buys 10,986 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 11, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 10,986 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. bought 10,986 shares of the firm's stock in a transaction on Wednesday, May 8th. The stock was purchased at an average cost of $13.70 per share, for a total transaction of $150,508.20. Following the completion of the acquisition, the insider now owns 3,140,590 shares in the company, valued at $43,026,083. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.May 10, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 10,713 SharesMay 8, 2024 | insidertrades.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires 10,713 Shares of StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 10,713 shares of Abrdn Life Sciences Investors stock in a transaction dated Monday, May 6th. The shares were bought at an average price of $13.62 per share, with a total value of $145,911.06. Following the completion of the acquisition, the insider now directly owns 3,079,443 shares of the company's stock, valued at $41,942,013.66. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.May 7, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $353,648.04 in StockMay 3, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 26,274 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 26,274 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were bought at an average price of $13.46 per share, for a total transaction of $353,648.04. Following the completion of the acquisition, the insider now owns 3,068,730 shares in the company, valued at $41,305,105.80. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.May 2, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 16,573 SharesMay 2, 2024 | insidertrades.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases 16,573 Shares of StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 16,573 shares of the firm's stock in a transaction that occurred on Tuesday, April 30th. The shares were bought at an average price of $13.13 per share, with a total value of $217,603.49. Following the acquisition, the insider now directly owns 3,042,204 shares in the company, valued at $39,944,138.52. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.May 1, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 120,304 SharesApril 30, 2024 | insidertrades.comXlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation ReportApril 30, 2024 | markets.businessinsider.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 120,304 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 120,304 shares of the stock in a transaction that occurred on Friday, April 26th. The shares were bought at an average price of $13.00 per share, with a total value of $1,563,952.00. Following the completion of the transaction, the insider now owns 3,025,602 shares in the company, valued at $39,332,826. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 29, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 20,529 SharesApril 27, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 20,529 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. bought 20,529 shares of the firm's stock in a transaction that occurred on Wednesday, April 24th. The stock was purchased at an average cost of $13.12 per share, with a total value of $269,340.48. Following the completion of the transaction, the insider now owns 2,807,724 shares in the company, valued at $36,837,338.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.April 26, 2024 | marketbeat.comWolverine Asset Management LLC Sells 114,766 Shares of Abrdn Life Sciences Investors (NYSE:HQL)Wolverine Asset Management LLC decreased its holdings in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 35.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,392April 24, 2024 | marketbeat.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires 2,022 Shares of StockApril 24, 2024 | insidertrades.comSaba Capital Management, L.P. Buys 2,022 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 2,022 shares of the stock in a transaction dated Monday, April 22nd. The shares were bought at an average cost of $12.88 per share, for a total transaction of $26,043.36. Following the acquisition, the insider now owns 2,738,992 shares in the company, valued at approximately $35,278,216.96. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.April 23, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $1,046,246.40 in StockApril 23, 2024 | insidertrades.comSaba Capital Management, L.P. Purchases 81,738 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 81,738 shares of the company's stock in a transaction on Thursday, April 18th. The shares were purchased at an average price of $12.80 per share, with a total value of $1,046,246.40. Following the completion of the purchase, the insider now directly owns 2,694,511 shares of the company's stock, valued at $34,489,740.80. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.April 22, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Shares Bought by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC lifted its position in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 30.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 454,154 shares of the company's stock afteApril 19, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Has $1.76 Million Position in Abrdn Life Sciences Investors (NYSE:HQL)Raymond James Financial Services Advisors Inc. grew its stake in Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 183.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 131,077 sharApril 11, 2024 | marketbeat.com Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! HQL Media Mentions By Week HQL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HQL News Sentiment▼2.000.77▲Average Finance News Sentiment HQL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HQL Articles This Week▼01▲HQL Articles Average Week Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies STEW News Today CET News Today MFIC News Today NMFC News Today BCSF News Today BBDC News Today HQH News Today CGBD News Today BTO News Today PHK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HQL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
